Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Biotech
Connect reduces China workforce, mulls strategy for asthma drug
In a year that has seen Connect walk away from a Pfizer collab and halt preclinical work, the biotech is now “significantly reducing” its China presence
James Waldron
Sep 6, 2024 4:37am
Aslan’s dream of challenging Dupixent dies as biotech winds down
Jul 17, 2024 8:36am
J&J scoops up another atopic dermatitis drug for $1.25B
May 28, 2024 8:30am
Connect uncouples from Pfizer by scrapping eczema pact
Apr 17, 2024 6:38am
Lilly's lebrikizumab clears eczema in people with skin of color
Mar 11, 2024 9:24am
Rapt faces clinical hold after liver failure in immunology trial
Feb 20, 2024 10:42am